Rapid Test for the Detection of IgM/IgG Antibodies to Zika Virus
The GENRAPI™ Zika Virus Rapid Card Kit is a lateral flow immunoassay developed for the qualitative detection of IgM and/or IgG antibodies against the Zika virus in human serum, plasma, or whole blood. This kit aids in the early diagnosis of Zika virus infection, a mosquito-borne disease that can cause significant health concerns such as microcephaly in newborns.
Designed for rapid screening, the test delivers reliable results within 15 to 20 minutes, making it ideal for use in hospitals, clinics, field settings, and emergency response situations.
Detects both IgM and IgG antibodies to Zika virus
Delivers results in 15–20 minutes
High diagnostic accuracy
Simple procedure; no lab equipment required
Suitable for field diagnostics and point-of-care use
Long shelf life and room temperature storage
Diagnosis of Zika virus infection
Use in areas with ongoing Zika virus outbreaks
Supports surveillance and public health monitoring
Can be used in primary healthcare and emergency settings
Test devices (individually sealed)
Sample collection devices (lancet or blood collection tube)
Buffer reagent
Instructions for use
Parameter | Details |
---|---|
Test Principle | Lateral flow immunoassay |
Sample Type | Serum, plasma, or whole blood |
Detection Target | IgM and IgG antibodies to Zika virus |
Result Time | 15–20 minutes |
Storage Conditions | 2–30°C (Room temperature) |
Shelf Life | 18–24 months from manufacturing date |
Sensitivity/Specificity | High, based on internal validation |
Copyright © 2025 https://probgenbiotech.com/ All Rights Reserved.